Here is a brief preview of this blast: On Tuesday, July 19, Gracell announced (press release) the appointment of Samuel Zhang as Chief Business Officer (CBO). Below, Celltelligence provides insights on how Gracell could leverage Zhang’s vast biopharma experience.
About The Author
The Celltelligence Team
Content Leads & Contributors
The Celltelligence team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.